Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.78
Delayed Data
As of 11:39am ET
 +0.05 / +2.89%
Today’s Change
1.53
Today|||52-Week Range
5.00
-3.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues3.0M34.4M11.5M15.2M
 
 
 
 
 
Cost of Goods Sold1.3M4.5M1.9M9.1M
 
 
 
 
 
Depreciation And Amortization3.6M3.7M3.5M--
 
 
 
 
 
Operating ExpensesGross Income-2.0M26.3M6.1M6.1M
 
 
 
 
 
General Expenses34.6M37.5M40.7M39.4M
 
 
 
 
 
Research And Development28.0M28.7M33.3M29.8M
 
 
 
 
 
Total Operating Expenses39.5M45.6M46.1M48.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.5M-11.2M-34.6M-33.3M
 
 
 
 
 
Extraordinary Charge-10.0K-1.0M-1.0M--
 
 
 
 
Interest Expense On Debt0.000.00674.0K4.9M
 
 
 
Other Expenses0.000.008.5M8.1M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
Net Income-36.5M-11.6M-27.8M-29.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.6M90.8M92.4M92.9M
 
 
 
 
 
Shares To Calculate EPS Diluted84.6M90.8M92.4M92.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.13-$0.30-$0.32
 
 
 
 
 
EPS Diluted-$0.43-$0.13-$0.30-$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account